158 related articles for article (PubMed ID: 1570714)
1. ABO-incompatible bone marrow transplantation: prevention of hemolysis by alkaline hydration with mannitol diuresis in conjunction with red cell reduced buffy coat bone marrow.
Slavc I; Urban C; Schwinger W; Hauer C; Vadon M
Wien Klin Wochenschr; 1992; 104(4):93-6. PubMed ID: 1570714
[TBL] [Abstract][Full Text] [Related]
2. ABO-incompatible bone marrow transplantation.
Wiesneth M; Hertenstein B; Bunjes D; Schmeiser T; Maccari B; Northoff H; Laasch H; Heit W; Arnold R; Heimpel H
Beitr Infusionsther; 1992; 30():354-8. PubMed ID: 1284733
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
4. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
5. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
Huang T; Sun J; Liu J; Liu QF; Men FY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
[TBL] [Abstract][Full Text] [Related]
6. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
7. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
[TBL] [Abstract][Full Text] [Related]
8. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
9. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
[TBL] [Abstract][Full Text] [Related]
12. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
[TBL] [Abstract][Full Text] [Related]
13. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
[TBL] [Abstract][Full Text] [Related]
14. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
Kalaycioglu M; Copelan E; Avalos B; Klein J; Goormastic M; Bolwell B
Bone Marrow Transplant; 1995 Jan; 15(1):105-10. PubMed ID: 7742742
[TBL] [Abstract][Full Text] [Related]
15. [Bone marrow transplantation with major ABO incompatibility. Experience at the bone marrow transplantation unit of the Center of Lisbon at the IPOFG].
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1993 Feb; 6(2):79-81. PubMed ID: 8488766
[TBL] [Abstract][Full Text] [Related]
16. [Delay in red blood cell recovery after major ABO incompatible bone marrow transplantation].
Fukuda M; Matsumoto K; Kojima S; Matsuyama T; Maeda H; Akatsuka Y; Tsuzuki S; Sughara T; Minami S; Kodera Y
Rinsho Ketsueki; 1991 Jan; 32(1):24-8. PubMed ID: 2020113
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
[TBL] [Abstract][Full Text] [Related]
18. Elevated inflammatory cytokine levels in bone marrow graft rejection.
Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
Transplantation; 1995 Nov; 60(9):943-8. PubMed ID: 7491698
[TBL] [Abstract][Full Text] [Related]
19. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
[TBL] [Abstract][Full Text] [Related]
20. Is the ABO incompatibility a risk factor in bone marrow transplantation?
Rozman P; Kosir A; Bohinjec M
Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
